logo

[breadcrumb_custom]

Autolus Therapeutics plc ADR (AUTL) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Autolus Therapeutics plc ADR’s current trading price is -23.76% away from its 52-week high, while its distance from the 52-week low is 252.80%. The stock’s price range for this time frame has been between $1.61 and $7.45. The trading volume of the company’s shares in the Healthcare reached around 2.4 million for the day, which was evidently higher than the average daily volume of 1.63 million over the last three months.

Autolus Therapeutics plc ADR’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $7.45 on 01/12/24, and the lowest price during that time was $1.61, recorded on 04/26/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

How Financial Performance Impacts Market Capitalization

Autolus Therapeutics plc ADR (AUTL) has experienced a quarterly decline of -14.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 988.89M and boasts a workforce of 463 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.62, with a change in price of +1.59. Similarly, Autolus Therapeutics plc ADR recorded 1,470,994 in trading volume during the last 100 days, posting a change of +38.88%.

How AUTL’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AUTL stands at 2.01. Similarly, the long-term debt-to-equity ratio is also 1.96.

AUTL Stock Stochastic Average

Autolus Therapeutics plc ADR’s raw stochastic average for the past 50 days is currently at 18.36%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 28.68%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 63.90% and 71.53%, respectively.

AUTL Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a loss of -11.80%.However, over the last six months, we can see a weaker performance of 135.68%. Over the last 30 days, the price of AUTL has leaped by -5.33%. And in the last five days, it has fallen by -10.13%.

On Key

Related Posts